Useful resources |
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients (Cochrane Review) ABSTRACT Background: Treatment with recombinant human erythropoietin (rHu EPO) in dialysis patients has been shown to be highly effective in terms of correcting anaemia and improving quality of life. There is debate concerning the benefits of rHu EPO use in pre-dialysis . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |